Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

How can we collaborate better as a multidisciplinary team to develop novel therapeutics?

COVID as a catalyst for remodelling approaches to early phase clinical trial development in a resource challenged environment

Date

10 Sep 2022

Session

How can we collaborate better as a multidisciplinary team to develop novel therapeutics?

Topics

Clinical Research;  COVID-19 and Cancer

Tumour Site

Presenters

Emiliano Calvo

Authors

E. Calvo

Author affiliations

  • Dept. Early Clinical Drug Development, Hospital Madrid Norte San Chinarro - Centro Integral Oncologico Clara Campal, 28050 - Madrid/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: How can we collaborate better as a multidisciplinary team to develop novel therapeutics?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.